Bullous pemphigoid: physiopathology, clinical features and management. (Q37045240)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18159905%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

Bullous pemphigoid: physiopathology, clinical features and management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18159905%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Giovanni Di Zenzo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18159905%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Gionata Marazza

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18159905%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Luca Borradori

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18159905%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18159905%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

published in

Advances in dermatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18159905%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18159905%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

257-288

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18159905%20AND%20SRC:MED&resulttype=core&format=json

Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Clinical variants of pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Localized pretibial pemphigoid and pemphigoid nodularis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Hydrostatic bullae and pretibial pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Dyshidrosiform pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Dyshidrosiform pemphigoid: report of three cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Childhood vulval pemphigoid: a clinical and immunopathological study of five patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

A vesicular bullous pemphigoid with an autoantibody against plectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Erythrodermic bullous pemphigoid is a clinical variant of bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Bullous pemphigoid presenting as exfoliative erythroderma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Extensive erosive bullous pemphigoid: an atypical and serious clinical variant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Acquired subepidermal bullous diseases associated with psoriasis: a clinical, immunopathological and immunogenetic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

A case of generalized pustular psoriasis followed by bullous disease: an atypical case of bullous pemphigoid or a novel bullous disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Coexistence of lichen planus and bullous pemphigoid. A immunopathological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Childhood bullous pemphigoid: report of a case with characterization of the targeted antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Drugs associated with bullous pemphigoid. A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Drug-induced pemphigoid: bullous and cicatricial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

The association of bullous pemphigoid and malignant disease: a case control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Bullous pemphigoid and autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Epitope spreading: lessons from autoimmune skin diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

The BPAG1 locus: Alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Structure and function of hemidesmosomes: more than simple adhesion complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Current insights into the formation and breakdown of hemidesmosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and alpha 6 integrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

The localization of bullous pemphigoid antigen 180 (BP180) in hemidesmosomes is mediated by its cytoplasmic domain and seems to be regulated by the beta4 integrin subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Analysis of the interactions between BP180, BP230, plectin and the integrin alpha6beta4 important for hemidesmosome assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Interaction of the bullous pemphigoid antigen 1 (BP230) and desmoplakin with intermediate filaments is mediated by distinct sequences within their COOH terminus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

The alpha 6 beta 4 integrin is a receptor for both laminin and kalinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Keratinocytes from patients lacking collagen XVII display a migratory phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

IgA antibodies of cicatricial pemphigoid sera specifically react with C-terminus of BP180

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Memory B cells specific for the NC16A domain of the 180 kDa bullous pemphigoid autoantigen can be detected in peripheral blood of bullous pemphigoid patients and induced in vitro to synthesize autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Characterization of bullous pemphigoid antibodies by use of recombinant bullous pemphigoid antigen proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

IgG antibodies from patients with bullous pemphigoid bind to fusion proteins encoded by BPAg1 cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Detection of autoantibodies against bullous pemphigoid and pemphigus antigens by an enzyme-linked immunosorbent assay using the bacterial recombinant proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Major antigenic epitopes of bullous pemphigoid 230 kDa antigen map within the C-terminal end of the protein. Evidence using a 55 kDa recombinant protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

BP230- and BP180-specific auto-antibodies in bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Epitope spreading in immune-mediated diseases: implications for immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

The intracellular and extracellular domains of BP180 antigen comprise novel epitopes targeted by pemphigoid gestationis autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kd bullous pemphigoid antigen and laminin 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Plectin, an unusual target antigen in bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Bullous pemphigoid and other basement membrane antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Molecular organization and function of the complement system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

The role of complement in experimental bullous pemphigoid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Role of different pathways of the complement cascade in experimental bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

A major role for neutrophils in experimental bullous pemphigoid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Role of FcRs in animal model of autoimmune bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

A critical role for neutrophil elastase in experimental bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Synergy between a plasminogen cascade and MMP-9 in autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Immunoadsorption against two distinct epitopes on human type XVII collagen abolishes dermal-epidermal separation induced in vitro by autoantibodies from pemphigoid gestationis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Humanization of autoantigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Rabbits immunized with a peptide encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Novel feline autoimmune blistering disease resembling bullous pemphigoid in humans: IgG autoantibodies target the NC16A ectodomain of type XVII collagen (BP180/BPAG2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

A spontaneously arising porcine model of bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Equine bullous pemphigoid IgG autoantibodies target linear epitopes in the NC16A ectodomain of collagen XVII (BP180, BPAG2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Enhanced diagnostic immunofluorescence using biopsies transported in saline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Comparative sensitivity of indirect immunofluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using a fusion protein representing an extracellular domain of the 180 kD bullous pemphigoid antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Development of an ELISA for the detection of autoantibodies to BP230.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Usefulness of BP180 NC16a enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Guidelines for the management of bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Bullous pemphigoid treatment review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Plasma exchange in bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Topical tacrolimus therapy for localized bullous pemphigoid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

High risk of death in elderly patients with extensive bullous pemphigoid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Why is the mortality of bullous pemphigoid greater in Europe than in the US?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Response to: mortality rate of bullous pemphigoid in a US medical center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Prediction of survival for patients with bullous pemphigoid: a prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Development of a system for detection of circulating antibodies against hemidesmosomal proteins in patients with bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

Production of the entire extracellular domain of BP180 (type XVII collagen) by baculovirus expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YADR.2007.07.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YADR.2007.07.013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18159905%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference